Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | STAT6 | P42226 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17281060 | 0.84 | MAOB (0.48) | ERN1ALDH1A1TDP1MGAMGAA | |
| SCHEMBL25807310 | 0.84 | ERN1 (0.48) | ERN1ALDH1A1CA1CA9CA2 | |
| SCHEMBL28639409 | 0.82 | ERN1 (0.55) | ERN1ALDH1A1CA1CA9CA2 | |
| SCHEMBL5180945 | 0.81 | ERN1 (0.48) | ERN1ALDH1A1CA1CA9GAA | |
| SCHEMBL6955307 | 0.81 | ERN1 (0.46) | ERN1ALDH1A1TDP1GAATP53 | |
| SCHEMBL19133572 | 0.78 | APP (0.57) | ERN1CA1CA9CA2APP | |
| SCHEMBL2875320 | 0.78 | ERN1 (0.48) | ERN1ALDH1A1TDP1CA1CA9 | |
| SCHEMBL12288740 | 0.77 | ALDH1A1 (0.59) | ALDH1A1TDP1MGAMGAASI | |
| SCHEMBL12854022 | 0.77 | APP (0.55) | ERN1CA1CA9CA2APP | |
| SCHEMBL848125 | 0.75 | CYP2A6 (0.50) | ERN1ALDH1A1TDP1CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-10749117-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| US-9893297-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-02-13 | — | — | US | disclosed |
| US-20170104165-A1 | MATERIALS FOR ELECTRONIC DEVICES | UDC IRELAND LIMITED (IE) | 2017-04-13 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | Life Technologies Corporation | 2015-09-03 | — | — | US | disclosed |
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | Life Technologies Corporation | 2015-09-03 | — | — | US | disclosed |
| WO-2012016630-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | Life Technologies Corporation (US) | 2011-02-03 | — | — | US | disclosed |
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | Life Technologies Corporation (US) | 2011-02-03 | — | — | US | disclosed |
| US-7816519-B2 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | Life Technologies Corporation (US) | 2010-10-19 | — | — | US | disclosed |
| US-7816519-B2 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | Life Technologies Corporation (US) | 2010-10-19 | — | — | US | disclosed |
| EP-2045252-A2 | Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings | Molecular Probes, Inc. (US) | 2009-04-08 | — | — | EP | disclosed |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | INVITROGEN CORPORATION (US) | 2007-04-26 | — | — | US | disclosed |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | INVITROGEN CORPORATION (US) | 2007-04-26 | — | — | US | disclosed |
| US-7169922-B2 | Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond | INVITROGEN CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
| US-7169922-B2 | Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond | INVITROGEN CORPORATION (US) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110027800-A1 | Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings | CYP3A7, UGT1A7, UGT2B7 | ERN1 4422/4885ALDH1A1 45/4885TDP1 2687/4885 |
| US-20070093652-A1 | longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands | CYP3A4, CYP3A5, UGT1A4 | ERN1 4592/4885ALDH1A1 140/4885TDP1 4253/4885 |
| US-20170104165-A1 | MATERIALS FOR ELECTRONIC DEVICES | EFNA1, CYP2C19, SDHB | ERN1 715/4885ALDH1A1 58/4885TDP1 1327/4885 |
| US-20150247863-A1 | DERIVATIVES OF 1,2-DIHYDRO-7-HYDROXYQUINOLINES CONTAINING FUSED RINGS | CYP3A7, UGT1A7, UGT2B7 | ERN1 4422/4885ALDH1A1 45/4885TDP1 2687/4885 |
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | OCIAD2, OCIAD1, DRD1 | ERN1 3224/4885ALDH1A1 1238/4885TDP1 1812/4885 |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, CRY1, CYP1B1 | ERN1 1668/4885ALDH1A1 13/4885TDP1 3358/4885 |
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | CYP1A1, CRY1, CYP1B1 | ERN1 1668/4885ALDH1A1 13/4885TDP1 3358/4885 |
| US-10749117-B2 | Materials for electronic devices | EFNA1, CYP2C19, SDHB | ERN1 715/4885ALDH1A1 58/4885TDP1 1327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.